DNA topoisomerase I inhibitors

Cancer Chemother Biol Response Modif. 1997;17:80-113.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Antiviral Agents / pharmacology
  • Camptothecin / adverse effects
  • Camptothecin / analogs & derivatives
  • Camptothecin / pharmacokinetics
  • Camptothecin / pharmacology
  • Camptothecin / therapeutic use
  • DNA Damage
  • DNA Topoisomerases, Type I / genetics
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Irinotecan
  • Neoplasms / drug therapy
  • Topoisomerase I Inhibitors*
  • Topotecan / pharmacokinetics
  • Topotecan / pharmacology
  • Topotecan / therapeutic use

Substances

  • Antineoplastic Agents
  • Antiviral Agents
  • Enzyme Inhibitors
  • Topoisomerase I Inhibitors
  • 9-aminocamptothecin
  • Irinotecan
  • Topotecan
  • DNA Topoisomerases, Type I
  • Camptothecin